IRCT20200105046010N66招募中未知
In- Vivo Bioequivalence study of Dasatonib tablet 100 mg Abidi Pharma (LARACEL® 100 mg Tab. Abidi Pharma, Iran) with brand drugs (SPRYCEL® 100 mg FC Tab, Bristol-Myers Squibb, UK) in Iranian healthy volunteers.
Abidi Pharmaceutical Company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •General health
- •Body mass index between18-28
- •Informed consent
- •Being at the age of 18-60 years old
排除标准
- •A history of cardiovascular disease
- •A history of liver & kidney disease
- •Alcohol & Drug addiction
- •Hypersensitivity to the drug
研究者
相似试验
招募中
不适用
In-vivo Bioequivalence Test of Dasatinib tablets with brand drug (SPRYCEL® 140 mg, Rosche, Switzerlandd)Plasma drug concentration.IRCT20200105046010N56anoalvand Pharmaceutical Co24
招募中
Unknown
Bioequivalence study of Dasatinib 100 mg tabletThis study is performed on healthy volunteers..IRCT20200105046010N81Actero Pharma Company24
招募中
不适用
Bioequivalence study of Dasatinib 50 mg tabletIRCT20200623047902N22Zistdaru danesh Co.48
招募中
不适用
In-vivo Bioequivalence Test of Dapoxetine tablet 30 mg Mofid Pharma with brand drug (PRILIGY® 30 mg Tab, Menarini, Italy)IRCT20200105046010N64Teb Mofid Nikan Pharmaceutical Co.24
招募中
不适用
In-vivo Bioequivalence study of Tadalafil tablet with brand drugs (CIALIS Lilly USA)IRCT20200105046010N39Mofid Pharmaceutical Co.24